TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36382669

Group type: EXPERIMENTAL
Intervention: 0.025% capsaicin gel with topical anesthetic
Number of subjects: 24

Group type: COMPARATOR
Intervention: Topical anesthetic monotherapy
Number of subjects: 24
Study: 33321014

Group type: EXPERIMENTAL
Intervention: Balloon catheter
Number of subjects: 180

Group type: COMPARATOR
Intervention: Basket catheter
Number of subjects: 180
Study: 35356610

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided anterior serratus plane block
Number of subjects: 94

Group type: COMPARATOR
Intervention: Brachial plexus block under ultrasound guidance
Number of subjects: 94
Study: 34037975

Group type: EXPERIMENTAL
Intervention: Oral sucrose solution (2 ml)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo (2 ml)
Number of subjects: 83
Study: 32144874

Group type: EXPERIMENTAL
Intervention: Standard adherence support (counselling, two-way SMS, monthly adherence clubs)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Standard support plus drug-level feedback
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard adherence support and drug-level feedback
Number of subjects: 67
Study: 35796125

Group type: EXPERIMENTAL
Intervention: SN60WF group
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: ZCB00 group
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: AO group
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: A1-UV group
Number of subjects: 181

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 181
Study: 33938520

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 144

Group type: COMPARATOR
Intervention: Amisulpride
Number of subjects: 144

Group type: COMPARATOR
Intervention: Aripiprazole
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Antipsychotic-naive participants
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Participants previously exposed to antipsychotics
Number of subjects: 144
Study: 35920410

Group type: EXPERIMENTAL
Intervention: Topical 10% lidocaine cream
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 10% lidocaine cream
Number of subjects: 40
Study: 32305061

Group type: EXPERIMENTAL
Intervention: Dynamic parameters of fluid-responsiveness
Number of subjects: 0

Group type: COMPARATOR
Intervention: Estimated oxygen extraction rate (O2ER)
Number of subjects: 0
Study: 36207036

Group type: EXPERIMENTAL
Intervention: Mobile Vaani intervention
Number of subjects: 4800
Study: 33638644

Group type: EXPERIMENTAL
Intervention: Feedback on quantity of antibiotic use (DDD, days-of-therapy)
Number of subjects: 4245

Group type: EXPERIMENTAL
Intervention: Feedback on validated quality indicators
Number of subjects: 4245

Group type: EXPERIMENTAL
Intervention: Feedback on non-validated quality indicators
Number of subjects: 4245
Study: 33239474

Group type: EXPERIMENTAL
Intervention: Full intervention (behavior change package + 4 chickens)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Partial intervention (behavior change package only)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Full intervention
Number of subjects: 260
Study: 33242835

Group type: EXPERIMENTAL
Intervention: Durvalumab therapy following chemoradiation
Number of subjects: 147

Group type: COMPARATOR
Intervention: Chemoradiation alone (historical cohort)
Number of subjects: 147
Study: 36375188

Group type: EXPERIMENTAL
Intervention: Septum-based double injection (DI group)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Single injection (SI group)
Number of subjects: 68
Study: 36127497

Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitor (SGLT2i) treatment for 12 weeks
Number of subjects: 68
Study: 33492733

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 17
Study: 34931289

Group type: EXPERIMENTAL
Intervention: Intraoperative infusion of dexmedetomidine 0.4 μg·kg‐1·hr‐1
Number of subjects: 104

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Intraoperative infusion of dexmedetomidine
Number of subjects: 104
Study: 34606500

Group type: EXPERIMENTAL
Intervention: EmpaTeach intervention (empathy-building exercises and group work for teachers)
Number of subjects: 1493

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 1493

Group type: EXPERIMENTAL
Intervention: EmpaTeach intervention
Number of subjects: 1493
Study: 32873686

Group type: EXPERIMENTAL
Intervention: TEXT4BP intervention (text messages containing information on hypertension, diet, medication and physical activity three times a week for 3 months)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 200
Study: 35962011

Group type: EXPERIMENTAL
Intervention: 80 Hz tACS
Number of subjects: 20

Group type: COMPARATOR
Intervention: 40 Hz tACS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study: 33564853

Group type: EXPERIMENTAL
Intervention: Experimental low-energy, low-protein formula (EF) supplemented with bovine MFGMs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard formula (SF)
Number of subjects: 0
Study: 36109030

Group type: EXPERIMENTAL
Intervention: Internet-based and mobile-based intervention (IMI) 'ACTonDiabetes'
Number of subjects: 210

Group type: COMPARATOR
Intervention: Enhanced treatment as usual (TAU+)
Number of subjects: 210
Study: 34130619

Group type: EXPERIMENTAL
Intervention: Gepotidacin (GSK2140944)
Number of subjects: 22
Study: 35114409

Group type: EXPERIMENTAL
Intervention: Mobile financial incentives (CM) for abstinence
Number of subjects: 532

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of the interventions
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Potential treatment mechanisms (self-efficacy, motivation, treatment engagement)
Number of subjects: 532
Study: 34467593

Group type: EXPERIMENTAL
Intervention: Vonafexor 400 mg once daily
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Vonafexor 200 mg twice daily
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Vonafexor/pegylated-IFN-?2a combination therapy
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73

Group type: COMPARATOR
Intervention: Entecavir
Number of subjects: 73
Study: 33837797

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) treatment consisting of three monthly sessions
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) consisting of 12 weekly sessions
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Combination of RF + PFMT
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 117
Study: 32785911

Group type: EXPERIMENTAL
Intervention: High-velocity resistance exercise (8 exercises using Thera-Band, 3 sets of 6 repetitions as fast as possible with moderate intensity)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control session
Number of subjects: 14
Study: 32835711

Group type: EXPERIMENTAL
Intervention: Liner applied (glass ionomer composite liner - Ionoseal, Voco)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No liner applied (control group)
Number of subjects: 30
Study: 34231332

Group type: EXPERIMENTAL
Intervention: Multiple Single Cannulation Technique (MuST)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Rope-Ladder Technique (RLC)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Buttonhole Technique (BHC)
Number of subjects: 172
Study: 34798853

Group type: EXPERIMENTAL
Intervention: 5 mg MPH + 10 mg escitalopram
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo + 10 mg escitalopram
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (MPH + escitalopram and placebo + escitalopram)
Number of subjects: 20
Study: 35809224

Group type: EXPERIMENTAL
Intervention: Synbiotic intervention
Number of subjects: 105
Study: 34143831

Group type: EXPERIMENTAL
Intervention: Biological larviciding with Bacillus thuringiensis israelensis (full or guided intervention)
Number of subjects: 127

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 127
Study: 33143794

Group type: EXPERIMENTAL
Intervention: Personalized depression risk information
Number of subjects: 712

Group type: COMPARATOR
Intervention: Control group (no personalized depression risk information)
Number of subjects: 712
Study: 35248830

Group type: EXPERIMENTAL
Intervention: Computerized multi-domain cognitive training (CT), 24 sessions over 8 weeks, 45 minutes each session
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Computerized multi-domain cognitive training (CT)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Active control intervention
Number of subjects: 136
Study: 33218533

Group type: COMPARATOR
Intervention: Static stretching
Number of subjects: 33

Group type: COMPARATOR
Intervention: Muscle energy technique stretching
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Vibration-assisted stretching
Number of subjects: 33
Study: 33191288

Group type: EXPERIMENTAL
Intervention: Systemic sclerosis (SSc)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Non-SSc comparators
Number of subjects: 76
Study: 32544561

Group type: EXPERIMENTAL
Intervention: Treat-and-extend (T&E) regimen
Number of subjects: 264

Group type: COMPARATOR
Intervention: Pro re nata (PRN) regimen
Number of subjects: 264
Study: 36361237

Group type: EXPERIMENTAL
Intervention: OFA combined with a paravertebral block with 0.5% bupivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Typical general anaesthesia with opioids
Number of subjects: 50
Study: 32653604

Group type: EXPERIMENTAL
Intervention: Bupivacaine injection (0.5 %, 5 mg/mL) at a dose of 4 ml for the umbilicus and 2 ml for each 5‐mm ancillary trocar site
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Bupivacaine injection (0.5 %, 5 mg/mL)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no bupivacaine administered)
Number of subjects: 108
Study: 35007962

Group type: EXPERIMENTAL
Intervention: Tuning in to Toddlers (TOTS) parenting program
Number of subjects: 300
Study: 35803290

Group type: EXPERIMENTAL
Intervention: CAS + IMD (1200 mg subcutaneous injection)
Number of subjects: 2317

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2317

Group type: EXPERIMENTAL
Intervention: CAS + IMD
Number of subjects: 2317
Study: 34423033

Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg per day for 12 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (3 mg per day for 12 weeks)
Number of subjects: 38
Study: 36314057

Group type: EXPERIMENTAL
Intervention: Dexamethasone 12 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexamethasone 6 mg daily
Number of subjects: 0
Study: 33434852

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA, n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham tDCS (n = 15)
Number of subjects: 30
Study: 36334724

Group type: EXPERIMENTAL
Intervention: Vaginal seeding (n=60; swabbed with gauze preincubated in maternal vagina)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Vaginal seeding (n=60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (n=60; routine standard care)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (n=60)
Number of subjects: 120
Study: 34622872

Group type: EXPERIMENTAL
Intervention: Acupuncture plus Tramadol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham acupuncture plus Tramadol
Number of subjects: 0
Study: 34506086

Group type: EXPERIMENTAL
Intervention: Complete decongestive therapy (CDT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Kinesiology taping (KT)
Number of subjects: 40
Study: 36343727

Group type: EXPERIMENTAL
Intervention: Cognitive task (Stroop test)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Deep breathing
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 20

Group type: COMPARATOR
Intervention: No-task
Number of subjects: 20
Study: 34269256

Group type: EXPERIMENTAL
Intervention: APRV
Number of subjects: 90

Group type: COMPARATOR
Intervention: SIMV-PC(P)
Number of subjects: 90

Group type: COMPARATOR
Intervention: SIMV-VC(V)
Number of subjects: 90
Study: 32310911

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 60
Study: 35249115

Group type: EXPERIMENTAL
Intervention: Nomogram-based blunt thoracic aortic injury screening model
Number of subjects: 305141

Group type: EXPERIMENTAL
Intervention: Multivariate analysis in the training cohort
Number of subjects: 305141
Study: 34450188

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 18667

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18667
Study: 33560163

Group type: EXPERIMENTAL
Intervention: Antimicrobial prophylaxis (211 patients)
Number of subjects: 474

Group type: COMPARATOR
Intervention: No antimicrobial prophylaxis (263 patients)
Number of subjects: 474
Study: 32503093

Group type: EXPERIMENTAL
Intervention: Ocrelizumab (OCR) 600 mg administered over a 2-hour infusion
Number of subjects: 580

Group type: COMPARATOR
Intervention: Ocrelizumab (OCR) 600 mg administered over a 3.5-hour infusion (conventional)
Number of subjects: 580
Study: 34525259

Group type: EXPERIMENTAL
Intervention: Everolimus-facilitated reduced-exposure tacrolimus (EVR + rTAC)
Number of subjects: 333

Group type: COMPARATOR
Intervention: Standard-exposure tacrolimus (sTAC)
Number of subjects: 333
Study: 33106280

Group type: EXPERIMENTAL
Intervention: Transmuscular quadratus lumborum (TQL) block with ropivacaine 60 mL 0.375%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (saline 60 mL)
Number of subjects: 50
Study: 33050920

Group type: EXPERIMENTAL
Intervention: IMRT with SIB (Arm A: whole breast 28 × 1.8 Gy, Boost 28 × 2.3 Gy)
Number of subjects: 446

Group type: COMPARATOR
Intervention: 3D-conformal radiotherapy with sequential boost (Arm B: whole breast 28 × 1.8 Gy, boost 8 × 2 Gy)
Number of subjects: 446
Study: 33813942

Group type: EXPERIMENTAL
Intervention: Experimental spelling training
Number of subjects: 108

Group type: COMPARATOR
Intervention: Waiting list condition (Control)
Number of subjects: 108
Study: 35144954

Group type: EXPERIMENTAL
Intervention: Stepped palliative care (PC) model, visits at clinically significant points unless QOL decreases, then every 4 weeks
Number of subjects: 510

Group type: COMPARATOR
Intervention: Early integrated palliative care (PC) model, visits every 4 weeks throughout illness
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Stepped palliative care (PC) model
Number of subjects: 510
Study: 32694372

Group type: EXPERIMENTAL
Intervention: BFR walking (200 mm Hg pressure cuffs, 5 km·h, 5 sets of 2-min walking with 1-min rest intervals)
Number of subjects: 24

Group type: COMPARATOR
Intervention: NBFR walking (no pressure cuffs, same walking protocol)
Number of subjects: 24
Study: 35110385

Group type: EXPERIMENTAL
Intervention: Physician judgement
Number of subjects: 4533

Group type: COMPARATOR
Intervention: Diamond‐Forrester (D‐F) estimates
Number of subjects: 4533

Group type: COMPARATOR
Intervention: European Society of Cardiology (ESC) estimates
Number of subjects: 4533
Study: 34781936

Group type: EXPERIMENTAL
Intervention: Telephone health coaching (THC) sessions (monthly, average 30 min for 12 months)
Number of subjects: 1535

Group type: COMPARATOR
Intervention: Usual health care services
Number of subjects: 1535

Group type: EXPERIMENTAL
Intervention: Telephone health coaching (THC)
Number of subjects: 1535
Study: 32857785

Group type: EXPERIMENTAL
Intervention: GoActive intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35180445

Group type: EXPERIMENTAL
Intervention: Synchronous stroking
Number of subjects: 82

Group type: COMPARATOR
Intervention: Asynchronous stroking (control condition)
Number of subjects: 82
Study: 34521963

Group type: EXPERIMENTAL
Intervention: Educational intervention for 30 minutes applied by a nurse
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 58
Study: 34922724

Group type: EXPERIMENTAL
Intervention: Tramadol (75 mg) + Dexketoprofen (25 mg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Ibuprofen (400 mg)
Number of subjects: 72
Study: 32663980

Group type: EXPERIMENTAL
Intervention: Real repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal controls (NCs)
Number of subjects: 60
Study: 35026038

Group type: EXPERIMENTAL
Intervention: Web-based brief intervention program for recording daily alcohol consumption for 4 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 100
Study: 33475224

Group type: EXPERIMENTAL
Intervention: Healthcare provider advice that it is acceptable to continue to smoke cigarettes in small amounts
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Perceived harm reduction of smoking light cigarettes
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Moderate to severe depression and anxiety score
Number of subjects: 217
Study: 33245865

Group type: EXPERIMENTAL
Intervention: Peer-delivered psychosocial intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33075775

Group type: EXPERIMENTAL
Intervention: Fluoride dentifrice with 5,000 µg F/g
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fluoride dentifrice with 1,300 µg F/g
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fluoride dentifrice with 0 µg F/g
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fluoride dentifrice with 700 µg F/g
Number of subjects: 10
Study: 32522095

Group type: EXPERIMENTAL
Intervention: Ticagrelor (loading dose: 180 mg, maintenance dose: 90 mg bid)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Clopidogrel (loading dose: 300 mg, maintenance dose: 75 mg qd)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 114

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 114
Study: 33234951

Group type: EXPERIMENTAL
Intervention: Upper blepharoplasty (conventional skin excision techniques)
Number of subjects: 316
Study: 34593298

Group type: EXPERIMENTAL
Intervention: Salmon calcitonin nasal spray
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 14
Study: 35108610

Group type: EXPERIMENTAL
Intervention: EFV 400 mg
Number of subjects: 420
Study: 35436807

Group type: EXPERIMENTAL
Intervention: Enhanced MRI nomogram model
Number of subjects: 116

Group type: COMPARATOR
Intervention: Rim arterial phase hyperenhancement
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Rim arterial phase hyperenhancement and enhanced capsule
Number of subjects: 116
Study: 33186308

Group type: EXPERIMENTAL
Intervention: Intercostal nerve block using 10 ml 0.35% ropivacaine (group MINB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional general anaesthesia (group CGA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intercostal nerve block (group MINB)
Number of subjects: 50
Study: 36417295

Group type: EXPERIMENTAL
Intervention: Positive video portrayal
Number of subjects: 82

Group type: COMPARATOR
Intervention: Negative video portrayal
Number of subjects: 82
Study: 34411275

Group type: EXPERIMENTAL
Intervention: Bundled care program including povidone-iodine skin preparation, nasal decolonization, iodine-alcohol surgical prepping solution, iodophor-impregnated incise drapes, forced-air warming blankets, and negative pressure wound therapy.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 32881945

Group type: EXPERIMENTAL
Intervention: Complementary feeding behavior change communication for 9 months
Number of subjects: 0
Study: 35653595

Group type: EXPERIMENTAL
Intervention: Combined bleaching (desensitizing gel for 10 minutes, in-office bleaching with 35% hydrogen peroxide for 2×15 minutes, followed by at-home bleaching with 4% hydrogen peroxide for 2×30 minutes for 21 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: At-home bleaching (4% hydrogen peroxide for 2×30 minutes for 21 days)
Number of subjects: 80
Study: 33596587

Group type: EXPERIMENTAL
Intervention: Self-reported sensitivity to reward (SR) in BD + AD group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Self-reported sensitivity to punishment (SP) in all clinical groups
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Behavioral response times
Number of subjects: 100
Study: 34666346

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with targeted sedation based on BIS values (BIS 60 to 70)
Number of subjects: 217
Study: 33556013

Group type: EXPERIMENTAL
Intervention: Thigh phase angle parameterization
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tibia phase angle parameterization
Number of subjects: 10

Group type: COMPARATOR
Intervention: Time parameterization
Number of subjects: 10
Study: 33438669

Group type: EXPERIMENTAL
Intervention: Real neurofeedback (direct transform of their motor imagery-related brain activity)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham feedback (related to someone else's brain activity)
Number of subjects: 28
Study: 34839398

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) underwent a mean negative energy balance of 270 (289) kcal/day, p < 0.001, resulting in a weight loss of -4.8 (4.9)% and fat mass loss of -11.3 (10.8)%. AT occurred in the IG, ranging from -65 to -230 kcal/day.
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control Group (CG) showed significant AT in three approaches.
Number of subjects: 94
Study: 34398083

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid-based dermal fillers
Number of subjects: 35
Study: 32729099

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg/bid from 48 hours before to 24 hours after the procedure with fixed maximal voltage (Group C)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Stepwise ramping voltage of ESWL (Group B)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Gradual ramping voltage with NAC (Group D)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Maximal fixed voltage of ESWL (Group A)
Number of subjects: 164

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 164
Study: 35798513

Group type: EXPERIMENTAL
Intervention: Full intervention package (school meals, school gardens, nutrition education, community workshops)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Partial intervention package (school garden, nutrition education, community workshops)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 750